DNER and cancer: Interestingly, in tumors cells, YAP targets are enriched in Myc regulated genes (32), possibly suggesting that co-activation by YAP and Myc, while potentiating gene expression, may also render cancer cells liable to BET inhibitors and more in general to transcriptional inhibitors.